Amica Mutual Insurance Co. Buys New Position in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Amica Mutual Insurance Co. bought a new stake in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 23,699 shares of the company’s stock, valued at approximately $1,451,000.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. Sequoia Financial Advisors LLC boosted its position in shares of Prestige Consumer Healthcare by 1.8% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 10,068 shares of the company’s stock valued at $576,000 after purchasing an additional 179 shares in the last quarter. Pinnacle Associates Ltd. boosted its holdings in Prestige Consumer Healthcare by 0.8% in the third quarter. Pinnacle Associates Ltd. now owns 24,672 shares of the company’s stock worth $1,411,000 after acquiring an additional 200 shares in the last quarter. Pacer Advisors Inc. boosted its holdings in Prestige Consumer Healthcare by 85.7% in the fourth quarter. Pacer Advisors Inc. now owns 442 shares of the company’s stock worth $27,000 after acquiring an additional 204 shares in the last quarter. Raymond James & Associates boosted its holdings in Prestige Consumer Healthcare by 0.4% in the third quarter. Raymond James & Associates now owns 96,433 shares of the company’s stock worth $5,515,000 after acquiring an additional 394 shares in the last quarter. Finally, GAMMA Investing LLC bought a new position in Prestige Consumer Healthcare in the fourth quarter worth approximately $25,000. Institutional investors own 99.95% of the company’s stock.

Insider Buying and Selling

In other Prestige Consumer Healthcare news, SVP Mary Beth Fritz sold 5,336 shares of the company’s stock in a transaction on Thursday, February 8th. The stock was sold at an average price of $69.00, for a total value of $368,184.00. Following the completion of the transaction, the senior vice president now owns 15,934 shares in the company, valued at approximately $1,099,446. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.60% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

PBH has been the topic of several recent research reports. TheStreet upgraded Prestige Consumer Healthcare from a “c+” rating to a “b-” rating in a report on Monday, February 12th. StockNews.com upgraded Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a report on Saturday, February 10th. One research analyst has rated the stock with a hold rating and two have given a buy rating to the company. Based on data from MarketBeat, Prestige Consumer Healthcare presently has an average rating of “Moderate Buy” and an average price target of $110.00.

Prestige Consumer Healthcare Stock Up 1.8 %

Shares of PBH stock traded up $1.27 during trading hours on Monday, reaching $71.74. The company had a trading volume of 124,156 shares, compared to its average volume of 236,192. Prestige Consumer Healthcare Inc. has a 12 month low of $55.96 and a 12 month high of $75.31. The company has a debt-to-equity ratio of 0.75, a current ratio of 3.09 and a quick ratio of 1.92. The business has a fifty day simple moving average of $70.93 and a 200-day simple moving average of $64.27. The company has a market cap of $3.56 billion, a price-to-earnings ratio of -43.74, a price-to-earnings-growth ratio of 1.91 and a beta of 0.52.

Prestige Consumer Healthcare (NYSE:PBH) last posted its earnings results on Thursday, February 8th. The company reported $1.06 earnings per share for the quarter, beating analysts’ consensus estimates of $1.04 by $0.02. Prestige Consumer Healthcare had a positive return on equity of 14.09% and a negative net margin of 7.11%. The company had revenue of $282.74 million for the quarter, compared to analyst estimates of $280.25 million. During the same quarter last year, the company earned $1.04 earnings per share. The company’s revenue for the quarter was up 2.6% on a year-over-year basis. On average, research analysts expect that Prestige Consumer Healthcare Inc. will post 4.33 earnings per share for the current fiscal year.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.